DuneGlass Capital
Overview
DuneGlass Capital is a private equity firm based in Chicago that focuses on growth investments in founder-led healthcare companies across the United States.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fecundis | Oct 2024 | Seed | Lead |
| LifeFlow Partners | Oct 2021 | Private Equity | Lead |
| Phase 1 Equity | Sep 2022 | Private Equity | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DuneGlass Capital based?
DuneGlass Capital is headquartered in Chicago, Illinois, United States.
When was DuneGlass Capital founded?
DuneGlass Capital was founded in 2018.
How many portfolio companies does DuneGlass Capital have?
DuneGlass Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in DuneGlass Capital's portfolio?
Portfolio companies visible on Caplight include Fecundis, LifeFlow Partners, Phase 1 Equity.
What was DuneGlass Capital's most recent investment shown here?
DuneGlass Capital's most recent investment in this portfolio sample was in Fecundis in 2024.
What sectors does DuneGlass Capital focus on?
DuneGlass Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does DuneGlass Capital focus on?
DuneGlass Capital typically invests at the Late stage.